Michele Libonati

Statistics

Publications

Citations

1.5K

H-Index

Active since

1992

Affiliations

St. Michael's Hospital(Current)

Michele Libonati is an author at St. Michael's Hospital specializing in monoclonal antibody therapy, therapeutic monoclonal antibodies, and pharmacotherapy.

Publications per year

1992–2007

Publications

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

Randomized multicenter trial of natalizumab in acute MS relapses

P. O’Connor, Andrew Goodman, A. Willmer–Hulme et al. · Neurology · 2004 · 168 citations

Life Sciences, Neurology, Pharmacology +16

Natalizumab Therapy for Moderate to Severe Crohn Disease in Adolescents

Jeffrey S. Hyams, Adrian G. Thomas, Robert Heuschkel et al. · Journal of Pediatric Gastroenterology and Nutrition · 2007 · 64 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +17

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

Timothy R. Vollmer, J. Theodore Phillips, Andrew Goodman et al. · Multiple Sclerosis Journal · 2004 · 43 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

SCH 39166, a novel dopamine D1 receptor antagonist: In vitro investigation of its glucuronidation and potential species differences

Clark E. Tedford, Vilma Ruperto, Vicki L. Coffin et al. · Drug Development Research · 1992 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 5